Cancer stem cells (CSCs) in esophageal cancer have a key role in tumor-initiation, progression, metastases, immune evasion, and therapy resistance. CSCs can be characterized by unique biomarkers, however, there exists an immense complexity of changing characteristics driven by tumor evolution and exposure to therapy. Attempts to target CSCs are ongoing but more in depth research is necessary.